Analysts See $-0.04 EPS for Theratechnologies Inc. (TH)

January 14, 2018 - By Henry Gaston

 Analysts See $ 0.04 EPS for Theratechnologies Inc. (TH)

Analysts expect Theratechnologies Inc. (TSE:TH) to report $-0.04 EPS on February, 14.After having $-0.04 EPS previously, Theratechnologies Inc.’s analysts see 0.00 % EPS growth. The stock decreased 2.60% or $0.21 during the last trading session, reaching $7.87. About 68,935 shares traded. Theratechnologies Inc. (TSE:TH) has 0.00% since January 14, 2017 and is . It has underperformed by 16.70% the S&P500.

Theratechnologies Inc. (TSE:TH) Ratings Coverage

Among 2 analysts covering Theratechnologies Inc. (TSE:TH), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Theratechnologies Inc. had 6 analyst reports since February 25, 2016 according to SRatingsIntel. The firm has “Outperform” rating by National Bank Canada given on Friday, November 11.

Theratechnologies Inc., specialty pharmaceutical company, addresses unmet medical needs to promote healthy living and an enhanced life among HIV patients. The company has market cap of $589.95 million. The Company’s lead product is EGRIFTA, which increases the incidence or progression of diabetic retinopathy in diabetic HIV-infected patients with lipodystrophy and excess abdominal fat in the United States and Canada. It currently has negative earnings.

More notable recent Theratechnologies Inc. (TSE:TH) news were published by: Marketwired.com which released: “Theratechnologies Hires New Chief Financial Officer” on February 24, 2016, also Seekingalpha.com with their article: “Theratechnologies Has An Unheralded Blockbuster” published on November 18, 2016, Marketwired.com published: “Theratechnologies Announces Financial Results for Fiscal Year 2016” on February 08, 2017. More interesting news about Theratechnologies Inc. (TSE:TH) were released by: Marketwired.com and their article: “Theratechnologies Inc.: Ibalizumab 24-Week Pivotal Phase III Study Results …” published on January 18, 2017 as well as Marketwired.com‘s news article titled: “Theratechnologies and TaiMed Biologics Sign Exclusive Marketing and …” with publication date: March 18, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.